Clinical Accelerator, a full-service, medical device focused contract research organization, is excited to announce a new collaboration with Argá Medtech, on their feasibility study exploring the safety and efficacy of Argá’s non-thermal cardiac ablation system targeting Atrial Fibrillation (AF)

The system is a next generation of Pulsed Field Ablation and Irreversible Electroporation, offering an alternative to RF and Cryo – the most commonly used sources of energy for cardiac ablation. The system is hoped to result in a safer and faster procedure with improved clinical outcomes for AF patients.

The study is planned to enrol 10 patients and will be managed by Clinical Accelerator at our partner sites. It is currently in the set-up phase, and we are very excited to see its progression!

About Clinical Accelerator

Clinical Accelerator is an independent clinical trial management organisation operating principally in Central and Eastern Europe. The organisation offers a broad range of clinical trial services together with dedicated patient enrolment support to worldwide clients in the pharmaceutical, biotechnological and medical device industries. Clinical Accelerator’s model of operation is designed to achieve significant cost savings for its clients and to guarantee compact timelines for patient enrolment with a firm focus on the quality of clinical trial data.